We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
+4.94%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
AUM
$6.98B
AUM Growth
+$857M
Cap. Flow
+$784M
Cap. Flow %
11.24%
Top 10 Hldgs %
16.48%
Holding
878
New
205
Increased
124
Reduced
98
Closed
184

Top Sells

Rank Stock Value
1
TER icon
Teradyne
TER
+$132M
2
QCOM icon
Qualcomm
QCOM
+$77.3M
3
ABT icon
Abbott
ABT
+$69.2M
4
BKNG icon
Booking.com
BKNG
+$67.7M
5
KLAC icon
KLA
KLAC
+$63.2M

Sector Composition

Rank Sector Weight
1 Healthcare 41.18%
2 Technology 29.45%
3 Communication Services 6.73%
4 Industrials 6.43%
5 Financials 4.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JNCE
176
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$11.4M 0.16%
+1,359,528
New +$11.2M
STVN icon
177
Stevanato
STVN
$5.57B
$11.2M 0.16%
500,000
CFLT
178
DELISTED
Confluent
CFLT
$11.2M 0.16%
146,287
+98,801
+208% +$7.13M
PARA
179
DELISTED
Paramount Global Class B
PARA
$11.1M 0.16%
367,770
-121,006
-25% -$4.17M
CHE icon
180
Chemed
CHE
$7.18B
$11.1M 0.16%
20,949
+1,000
+5% +$480K
GOSS icon
181
Gossamer Bio
GOSS
$81.7M
$11.1M 0.16%
+977,823
New +$11.6M
EXEL icon
182
Exelixis
EXEL
$13.7B
$11M 0.16%
601,800
EXAI
183
DELISTED
Exscientia Plc American Depositary Shares
EXAI
$10.9M 0.16%
+551,711
New +$11.6M
NBIX icon
184
Neurocrine Biosciences
NBIX
$16.9B
$10.9M 0.16%
127,643
-502,194
-80% -$46.2M
ZD icon
185
Ziff Davis
ZD
$1.99B
$10.8M 0.16%
97,768
-8,706
-8% -$1.03M
OM icon
186
Outset Medical
OM
$90.6M
$10.6M 0.15%
15,400
+1,521
+11% +$1.12M
CCMP
187
DELISTED
CMC Materials, Inc. Common Stock
CCMP
$10.5M 0.15%
+54,894
New +$7.96M
ZGNX
188
DELISTED
Zogenix, Inc.
ZGNX
$10.4M 0.15%
642,465
+216,325
+51% +$3.17M
WK icon
189
Workiva
WK
$3.42B
$10.4M 0.15%
+79,959
New +$11.3M
LH icon
190
Labcorp
LH
$25B
$10.4M 0.15%
38,498
-95,185
-71% -$23.6M
BL icon
191
BlackLine
BL
$1.93B
$10.3M 0.15%
99,837
+16,694
+20% +$1.94M
HMCO
192
DELISTED
HumanCo Acquisition Corp. Class A Common Stock
HMCO
$10.3M 0.15%
1,054,421
-900
-0.1% -$8.88K
SHOP icon
193
Shopify
SHOP
$153B
$10.3M 0.15%
+74,500
New +$10.9M
CLDX icon
194
Celldex Therapeutics
CLDX
$2.95B
$10M 0.14%
+259,895
New +$11.3M
CCO icon
195
Clear Channel Outdoor Holdings
CCO
$1.23B
$10M 0.14%
3,027,008
-1,419,966
-32% -$4.42M
IMTX icon
196
Immatics
IMTX
$1.23B
$9.99M 0.14%
743,490
+137,570
+23% +$1.72M
KN icon
197
Knowles
KN
$3.19B
$9.96M 0.14%
426,681
-300,429
-41% -$6.34M
RXDX
198
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$9.9M 0.14%
250,326
+42,789
+21% +$1.34M
ULTA icon
199
Ulta Beauty
ULTA
$22.7B
$9.9M 0.14%
+24,003
New +$9.33M
FTV icon
200
Fortive
FTV
$18B
$9.88M 0.14%
+171,931
New +$9.72M

Similar funds

Woodline Partners's Q4 2021 Portfolio in Review

As of Q4 2021, Woodline Partners held 878 positions worth $6.98B, up 14% from $6.12B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Woodline Partners deployed $784M of net new capital in Q4 2021, opening 205 new positions and adding to 124 existing holdings. Its largest new stake was Qorvo: 963,210 shares worth $151M.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, down from 46% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was KLA, an estimated $63.2M trimmed.

  • Woodline Partners's largest Q4 2021 buy was Qorvo: 963,210 shares worth $151M.
  • Woodline Partners added most to ASML in Q4 2021, an estimated $117M increase.
  • Woodline Partners's biggest Q4 2021 reduction was KLA, cutting an estimated $63.2M.
  • Woodline Partners fully exited Teradyne in Q4 2021, selling an estimated $132M.
  • Woodline Partners's ten largest holdings make up 16% of its $6.98B portfolio in Q4 2021.
  • Woodline Partners opened 205 new positions and closed 184 in Q4 2021.
  • Woodline Partners's portfolio value rose 14% quarter-over-quarter to $6.98B.

Based on Woodline Partners's 13F filing for Q4 2021, filed 14 Feb 2022.